Recent Advances in the Treatment of HIV/HBV and HIV/HCV Co-Infection

Author(s): A. Masgala, S. Bonovas, G. K. Nikolopoulos.

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 12 , Issue 9 , 2012

Become EABM
Become Reviewer


Concurrent infection with hepatitis B virus (HBV) and hepatitis C virus (HCV) in patients positive for human immunodeficiency virus (HIV) is relatively common. The treatment of co-infected individuals is rather complex because the anti-viral therapy may be associated with drug-resistance, hepatotoxicity and lack of response. Herein, we present a summary of the available compounds and the recent recommendations concerning the therapeutic management of HIV/HBV and HIV/HCV co-infections.

Keywords: HIV, HBV, HCV, co-infection, treatment, drugs, hepatitis B, hepatocellular carcinoma, adefovir, lamivudine, entecavir

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [890 - 904]
Pages: 15
DOI: 10.2174/138955712800959062
Price: $58

Article Metrics

PDF: 13